<DOC>
	<DOCNO>NCT00849576</DOCNO>
	<brief_summary>The purpose study compare effect insulin VIAject Regular Human Insulin Insulin Lispro measure mealtime blood vessel stress blood flow .</brief_summary>
	<brief_title>Effect Treatment With Insulin VIAjectTM Compared Regular Human Insulin Insulin Lispro Mealtime Blood Vessel Stress Patients With Type 2 Diabetes Mellitus .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>1 . Type 2 diabetes mellitus accord ADA criterion 2 . HbA1c 6.5 % 9.9 % 3 . Treatment sulfonylurea and/or metformin stable dosage within last 3 month 4 . Age 40 75 year 5 . BMI &lt; 40 1 . Type 1 diabetes mellitus 2 . Pretreatment insulin within last 6 month prior screen 3 . Pretreatment PPARyagonists glucosidase inhibitor within last 4 week prior screen 4 . Untreated hypertension stage IIIII accord WHO criteria 5 . Planned anticipated change antidiabetic and/or concomitant medication study participation 6 . Total cholesterol &gt; 300 mg/dl ( anamnestically ) 7 . Major micro macrovascular complication judge investigator 8 . Tobacco use within last 6 month prior screen 9 . Drugs major impact endothelial function like nitrate etc . 10 . History drug alcohol abuse opinion investigator impair subject safety protocol compliance 11 . History hypersensitivity study drug drug similar chemical structure 12 . History severe multiple allergy 13 . Treatment investigational drug within 3 month prior screen 14 . Progressive fatal disease 15 . History significant cardiovascular , respiratory , gastrointestinal , hepatic ( ALAT and/or ASAT &gt; 3 time normal reference range ) , renal ( creatinine &gt; 1.1 mg/dL woman &gt; 1.5 mg/dL men ) , neurological , psychiatric and/or haematological disease judge investigator 16 . Pregnancy breast feed 17 . Sexually active woman childbearing potential consistently correctly practice birth control implant , injectables , oral contraceptive , hormonal intrauterine device ( IUDs ) , sexual abstinence vasectomise partner 18 . Lack compliance similar reason discretion investigator precludes satisfactory participation study 19 . Hypopotassemia ( K &lt; 3.5 mmol /l )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>